首页
登录
职称英语
[originaltext]Worldwide, cervical cancer is tile third most common type of canc
[originaltext]Worldwide, cervical cancer is tile third most common type of canc
游客
2025-01-01
40
管理
问题
Worldwide, cervical cancer is tile third most common type of cancer in women. So news that a vaccine is to be put on the market has been hailed as a major breakthrough. The drug Gadsill protects women against some strains of the virus HPV, which triggers cancer in a portion of the uterus. It’s been developed by tile American pharmaceutical company Merk and it’s now been approved by the authorities for use within the US. The death rate from cervical cancer is falling in rich countries as it’s frequently detected at an early stage, However, it is still a major cause of death in the developing world.
选项
A、Surprised.
B、Indifferent.
C、Suspicious.
D、Excited.
答案
D
解析
转载请注明原文地址:https://www.tihaiku.com/zcyy/3893489.html
相关试题推荐
[originaltext]TomHanks,JuliaRoberts,ERandFriendsweresomeofthebig
[originaltext]TomHanks,JuliaRoberts,ERandFriendsweresomeofthebig
[originaltext]Mr.Williams:Goodmorning,Mr.Pitt.Dositdown.Mr.Pitt:Than
[originaltext]Mr.Williams:Goodmorning,Mr.Pitt.Dositdown.Mr.Pitt:Than
[originaltext]Mr.Williams:Goodmorning,Mr.Pitt.Dositdown.Mr.Pitt:Than
[originaltext]TheUnitedStateshasproposedwithdrawingabout1/3ofAmeric
[originaltext]TheUnitedStateshasproposedwithdrawingabout1/3ofAmeric
[originaltext]InSaudiArabia,6influentialSaudipreachershavedenounced
[originaltext]NowEuropeanfinanceministersareexpectedtoreprimandtheI
[originaltext]NowEuropeanfinanceministersareexpectedtoreprimandtheI
随机试题
Forsomebirdsthesenseofsmellappearstoplayaroleinnavigation,sincepi
[originaltext]Howmanymendohousework?RecentlyaEuropeancommissiontri
Whichofthefollowingdiagramsistheoddoneout?[img]2014m4s/ct_eyyjsdz2012c_
A
按照《证券公司内部控制指引》的要求,证券公司内部控制的组织结构要求设立严密有效的
为鼻饲患者灌注食物时,每次鼻饲量不宜超过A.100ml B.200ml C.
我国现行统计制度对批发商(业)的分类是按()进行的。A:销售地区 B:经营主体
()定义为期权价格的变化与波动率变化的比率。A.DeltA B.GammA
A.滋阴补肾,清肝明目 B.补益肝肾,活血明目 C.活血化瘀,养肝明目 D
下列有关贴剂(TDDS)的特点,错误的是A.可避免肝脏的首关效应 B.可延长药
最新回复
(
0
)